Rashes and Rebound effect
Summary:
Rebound effect is found among people with Rashes, especially for people who are female, 20-29 old.
The study analyzes which people have Rebound effect with Rashes. It is created by eHealthMe based on reports of 43 people who have Rashes from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Rashes?
Rashes (redness) is found to be associated with 3,714 drugs and 6,213 conditions by eHealthMe. Check the latest studies of Rashes.
What is Rebound effect?
Rebound effect (take-back effect) is found to be associated with 372 drugs and 567 conditions by eHealthMe. Check the latest studies of Rebound effect.
43 people who have Rashes and Rebound Effect are studied.

Gender of people who have Rashes and experienced Rebound Effect *:
- female: 69.05 %
- male: 30.95 %
Age of people who have Rashes and experienced Rebound Effect *:
- 0-1: 0.0 %
- 2-9: 2.94 %
- 10-19: 8.82 %
- 20-29: 29.41 %
- 30-39: 14.71 %
- 40-49: 5.88 %
- 50-59: 11.76 %
- 60+: 26.47 %
Common co-existing conditions for these people *:
- Erythrodermic Psoriasis (generalized redness of the skin): 5 people, 11.63%
- Psoriasis (immune-mediated disease that affects the skin): 4 people, 9.30%
- Oedema (fluid collection in tissue): 4 people, 9.30%
- Klebsiella Infection: 4 people, 9.30%
- Rosacea (a skin condition that causes facial redness): 3 people, 6.98%
- Skin Blushing/flushing (a sudden reddening of the face, neck): 2 people, 4.65%
- Pleural Effusion (water on the lungs): 2 people, 4.65%
- Dermatitis Allergic (inflammation of the skin due allergic reaction): 2 people, 4.65%
- Coronary Heart Disease (narrowing or blockage of the coronary arteries): 2 people, 4.65%
- Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 2.33%
Common drugs taken by these people *:
- Mirvaso: 18 people, 41.86%
- Prednisone: 6 people, 13.95%
- Promethazine: 4 people, 9.30%
- Dupixent: 3 people, 6.98%
- Cosentyx: 3 people, 6.98%
- Lumify: 2 people, 4.65%
- Methylprednisolone: 2 people, 4.65%
- Loratadine: 2 people, 4.65%
- Baclofen: 1 person, 2.33%
- Ciprofloxacin: 1 person, 2.33%
Common symptoms for these people *:
- Skin Blushing/flushing (a sudden reddening of the face, neck): 13 people, 30.23%
- Erythrodermic Psoriasis (generalized redness of the skin): 5 people, 11.63%
- Paleness (unusual lightness of skin colour): 5 people, 11.63%
- Drug Ineffective: 4 people, 9.30%
- Feeling Hot: 3 people, 6.98%
- Liver Function Test Abnormal: 3 people, 6.98%
- Pathogen Resistance: 3 people, 6.98%
- Ocular Hyperaemia (an abnormally large amount of blood in eye): 2 people, 4.65%
- Itching: 2 people, 4.65%
- Weight Increased: 2 people, 4.65%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Rebound effect?
- Check whether Rebound effect is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Rashes (702,909 reports)
- Rebound effect (8,859 reports)
All the drugs that are associated with Rebound effect:
- Rebound effect (372 drugs)
All the conditions that are associated with Rebound effect:
- Rebound effect (567 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Rebound effect and Rashes, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Entocort Ec vs. Asacol Hd, side effect and effectiveness comparison - 2 seconds ago
- Drug interactions of Praluent and Levoxyl - 3 seconds ago
- Could Montelukast Sodium cause Abnormal Behavior? - 9 seconds ago
- Drug interactions of Tenofovir Disoproxil Fumarate and Darunavir - 16 seconds ago
- Could Carbidopa cause Head Injury? - 16 seconds ago
- Could Cefazolin Sodium cause Osteoarthritis Aggravated? - 21 seconds ago
- Multiple Allergies and Renal Pain - 28 seconds ago
- Drug interactions of Diltiazem Hydrochloride and Midazolam Hydrochloride - 31 seconds ago
- Ankylosing Spondylitis and Tuberculosis - 38 seconds ago
- Could Zestoretic cause Hot Flush? - 40 seconds ago